Carbamazepine

CAS 298-46-4 18 current records 14 historicalSmall Molecule

Who holds supplier records for Carbamazepine? 18 organisations hold a current record for Carbamazepine: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (2), Switzerland (1), Italy (1) and 4 other countries (4); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Carbamazepine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/carbamazepine

Reading the evidence

  • 18 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (18)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Carbamazepine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Carbamazepine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Carbamazepine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TARO PHARMACEUTICAL INDUSTRIES, LTD. HaifaIL
CEP 1998-087 - Rev 12
Carbamazepine, Product codes: S40070, S10234 and S50387
Nov 2026Inspected Feb 2025
Israel
JUBILANT BIOSYS LIMITED MysuruIN
CEP 1999-109 - Rev 09
Carbamazepine
Sept 2026—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2021-129 - Rev 02
Carbamazepine, Process II
May 2026—
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2024-233 - Rev 00
Carbamazepine
Sept 2025—
BAJAJ HEALTHCARE LIMITED ThaneIN
CEP 2021-339 - Rev 01
Carbamazepine
Aug 2025—
TAPI NL B.V. AmsterdamNL
CEP 2000-164 - Rev 06
Carbamazepine
Jul 2025—
ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdańskiPL
CEP 2004-141 - Rev 04
Carbamazepine, standard, milled, micronised
Dec 2024Inspected Jul 2026
Poland
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2003-271 - Rev 05
Carbamazepine
Feb 2022—
PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard GdanskiPL
R1-CEP 2012-353 - Rev 01
Carbamazepine, Crystallised in ethanol
Jan 2021—
CTX LIFESCIENCES PVT. LIMITED SuratIN
R1-CEP 2014-149 - Rev 00
Carbamazepine
Nov 2020—
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou CityCN
R1-CEP 2002-221 - Rev 06
Carbamazepine
Feb 2019—
ZHEJIANG RAYBOW PHARMACEUTICAL CO., LTD. Taizhou CityCN
R1-CEP 2012-135 - Rev 00
Carbamazepine, Process B
May 2018—
AREVIPHARMA GMBH RadebeulDE
R1-CEP 2005-011 - Rev 05
Carbamazepine
Jan 2017—
SIEGFRIED EVIONNAZ SA EvionnazCH
R1-CEP 1998-086 - Rev 05
Carbamazepine
Dec 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (14)

Organisations whose Type II DMFs for Carbamazepine are no longer active. These show a past filing, not current supply.

Show all 14 historical records
  • Germany · Inactive DMF 20376, 23328 · filed Dec 2009
  • TEVA GROUP
    Inactive DMF 13125 · filed Aug 1998
  • MAX INDIA LTD
    Inactive DMF 12512 · filed May 1997
  • ARZNEIMITTELWERK DRESDEN GMBH
    Inactive DMF 11901 · filed Mar 1996
  • FARCHEMIA SRL
    Inactive DMF 9967 · filed Nov 1992
  • France · Inactive DMF 7904 · filed Feb 1989
  • CL PHARMA AG
    Inactive DMF 7815 · filed Dec 1988
  • VIS FARMACEUTICI INSTITUTO SCIENTIFICO VINEZIE SPA
    Inactive DMF 7827 · filed Dec 1988
  • FREEDOM CHEMICAL DIAMALT GMBH
    Inactive DMF 7744 · filed Oct 1988
  • AMERICAN CHEMICAL INDUSTRIAL CORP
    Inactive DMF 7288 · filed Jan 1988
  • SHANGHAI NO 2 PHARMACEUTICAL FACTORY
    Inactive DMF 7163 · filed Oct 1987
  • Italy · Inactive DMF 6742 · filed Dec 1986
  • HEXAGON LABORATORIES INC
    Inactive DMF 6748 · filed Dec 1986
  • Finland · Inactive DMF 5665 · filed Dec 1984

Overview

Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and bipolar disorder. It is also used to relieve trigeminal neuralgia, a disorder that causes severe facial nerve pain.

Chemical identity

IUPAC name
benzo[b][1]benzazepine-11-carboxamide
Canonical SMILES
C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
InChIKey
FFGPTBGBLSHEPO-UHFFFAOYSA-N
Synonyms
Tegretol API, biston, carbamazepinum, carbatrol, carnexiv, carbamazepine anhydrous, carbamazepine extended release, epitol, equetro, finlepsin, g-32883, geigy 32883

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Mood Stabilizer
Mechanism of action
Cytochrome P450 1A2 Inducers; Cytochrome P450 2B6 Inducers; Cytochrome P450 2C19 Inducers; Cytochrome P450 2C9 Inducers; Cytochrome P450 3A4 Inducers
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

NeurologyPsychiatry

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Carbamazepine?

18 organisations hold an active US FDA Type II Drug Master File or a CEP for Carbamazepine: JUBILANT BIOSYS LTD (India), SIEGFRIED EVIONNAZ SA (Switzerland), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), TAPI NL BV (Netherlands), Taro Pharmaceutical Industries Ltd. (Israel), Zakłady Farmaceutyczne Polpharma S.A. (Poland), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India) and CTX LIFE SCIENCES PVT LTD (India), and 10 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Carbamazepine Drug Master Files are active?

JUBILANT BIOSYS LTD (DMF 43462, 14410), SIEGFRIED EVIONNAZ SA (DMF 4341, 15195), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 6641), TAPI NL BV (DMF 4719), Taro Pharmaceutical Industries Ltd. (DMF 4929), Zakłady Farmaceutyczne Polpharma S.A. (DMF 26266), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 23170) and CTX LIFE SCIENCES PVT LTD (DMF 24195) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Carbamazepine records mean?

14 organisations have only inactive Type II DMFs for Carbamazepine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Carbamazepine have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Carbamazepine on the EDQM register, including TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa (IL), JUBILANT BIOSYS LIMITED Mysuru (IN), AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN), ARENE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), BAJAJ HEALTHCARE LIMITED Thane (IN) and TAPI NL B.V. Amsterdam (NL) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Carbamazepine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Carbamazepine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.